Catalyst Wire Dossier Catalyst Wire Dossier

Evoglitin

· Dong-A ST Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Evoglitin, covering 2021-04-29 to 2021-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases [Phase 4]

See pricing